Business Wire

Emulate Announces Strategic Collaboration with Johnson & Johnson Innovation to Use Organs-on-Chips Platform to Better Predict Human Response in Drug Development Process

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Emulate, Inc. today announced that it recently formed a research collaboration with Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson ...
Business Wire

Emulate, Inc. Unveils the Chip-R1™ Rigid Chip with a Minimally Drug-Absorbing Profile to Improve Biological Modeling for ADME and Toxicology Applications

BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug ...
MarketWatch

Emulate Applauds FDA's Roadmap to Reduce Animal Testing and Embrace Organ-Chip Technologies

Emulate, Inc., a leading provider of next-generation in vitro models, today welcomed the U.S. Food and Drug Administration's (FDA) newly announced plan to reduce reliance on animal testing in ...
News Medical

Scaling organ‑chip technology for human‑relevant drug discovery

insights from industryJim CorbettCEOEmulate, Inc. In this interview, NewsMedical speaks with Jim Corbett, CEO of Emulate, Inc., about the development and impact of the AVA Emulation System and how it ...